Scope and Aim

Monoclonal antibodies are one of the most important classes of therapeutic recombinant proteins. They are under clinical evaluation for a broad range of important therapeutic areas including cancer, rheumatoid arthritis and infectious diseases. Significantly, classical Biotech companies are no longer the only players and traditional large Pharma companies have now also recognised the potential of recombinantly manufactured monoclonal antibodies.

This Workshop will cover a broad spectrum of topics from the design and engineering of monoclonal antibodies, through process development (e.g. cell line optimisation and down stream processing), analytics, formulation aspects and manufacturing up to clinical applications. An important element of the Workshop will be the attention paid to current regulatory requirements for the introduction of monoclonal antibodies. Trends towards modification of antibodies by conjugation or subsequent glycosylation as well as their reduction in size to antibody fragments such as domain or single chain antibodies will also be discussed.

Topics Covered

• New technologies for design of antibodies and engineering
• Latest advancements in ustream development including expression systems and feed strategies
• Downstream development including purification and recovery optimisation
• Physical characterisation, formulation and delivery systems
• Scale-up issues and production scale manufacturing
• Analytics and specs
• Clinical update (new antibody therapies), commercial impact and new trends
• Pharmacokinetic and safety
• Armed antibodies and new classes of antibodies or antibody derivatives
• Future of antibody therapeutics: What are the next steps?

Scientific Planning Committee

Karoline Bechtold-Peters, Boehringer-Ingelheim, Germany (Co-Chair)
Wim Jiskoot, Leiden/Amsterdam Center for Drug Research (LACDR), The Netherlands (Co-Chair)
Daan J.A. Crommelin, Dutch Top Institute Pharma, The Netherlands
Hans H. Linden, EUFEPS, Stockholm, Sweden
Barry Moore, XstalBio, United Kingdom
Wayne Gombotz, Omeros Corp., USA
Jan van de Winkel, Genmab, The Netherlands
Sven Stegemann, Capsugel, Belgium

EAPB www.eapb.org
EAPB is a professional association dedicated to the advancement of biotechnology in pharmaceutical sciences, specifically as applied to industrial materials, processes, products and their associated challenges. Its members constitute scientists employed in industry, government and university laboratories, biotech companies and scientific organisations.

EUFEPS www.eufeps.org
Founded in 1991, the mission of EUFEPS is to advance excellence in the pharmaceutical sciences and innovative drug research, and to represent the interests of scientists engaged in drug research and development, drug regulation and drug policymaking. Currently, EUFEPS links 24 Member Societies in 24 European countries.

AAPS www.aaps.org
AAPS is a professional scientific society of more than 12,000 members employed in academia, industry,  government and other research institutes worldwide.  Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health.

FIP www.fip.org
FIP, founded in The Hague, more than 90 years ago, is the worldwide federation of national pharmaceutical, professional and scientific, associations, with a mission to represent and serve pharmacy and pharmaceutical sciences around the globe.  Through its member association, FIP connects, represents and serves more than a million pharmacists and pharmaceutical scientists around the world.

Registration

For registration fee, see table below (including 19 % VAT). EAPB or EUFEPS Members will receive 10% reduction. Should they – or other – also register to the PSWC2007, there is an additional reduction. The fee includes all Workshop documentation, all coffee breaks and meals. The cost for hotel accommodation and travel is not included in the registration fee.

To register to this Workshop, click:

MAB Workshop Online Delegate Registration Form

Payment

Please indicate your name and 0752 (Payment reference number) on your money transfer.
 
Account holder: Congrex Sweden AB, Att: EUFEPS MAB 2007, 
P.O.Box 5619, SE-114 86 Stockholm, Sweden
 
Bank: Handelsbanken, Box 7190 SE-103 88 Stockholm, Sweden
Swift/BIC-code: HANDSESS
Account no: 6137-043484239
IBAN no: SE24 6000 0000 0000 4348 4239
 
Please note that you need to send a copy of your bank transfer when made later than March 30th 2007.

Students

Participants applying for student fees should include proof of their student status (a photocopy of the university identity card).

Confirmation

In order to receive confirmation of registration by email, please make sure to indicate the email address on the registration form! Confirmation will be sent upon receipt of payment.

Alterations

Alterations to your registration must be made in writing and sent to Congrex Sweden AB by email or fax.

Inquiries

Congrex Sweden AB has been contracted for registration, accommodation and administration support. Please direct all inquiries regarding registration, accommodation or payment to Congrex Sweden AB at: mab.registration@congrex.com
Tel +46 8 4596600
Fax +46 8 6619125

Hotel Reservation

For accommodation, please take advantage of the Hotel Reservation procedures of the PSWC 2007, provided by the RAI Hotel & Travel Service.
For online hotel reservation, click: Hotel booking PSWC2007 online

Useful addresses

European Federation for Pharmaceutical Sciences
EUFEPS Secretariat
PO Box 1136
SE-111 81 Stockholm
Sweden
Tel +46 8 7235000
Fax +46 8 4113217
Email conferences@eufeps.org
Website www.eufeps.org

European Association of Pharma Biotechnology
EAPB Secretariat
Kelchstraße 31
DE- 12169 Berlin
Germany
Tel +49 30 838 506 96
Fax +49 30 838 506 16
Email info@eapb.org
Website www.eapb.org